Followers | 29 |
Posts | 1016 |
Boards Moderated | 0 |
Alias Born | 05/25/2005 |
Tuesday, March 17, 2015 12:33:38 AM
The implosion of oil prices and resulting depression of exploration company share prices has taken its toll on ERHC, not to mention the likely effects of toxic convertible debt financing.
Still, there have been positive developments: Work in Kenya and Chad is progressing; Chrome (SEO) has finally stepped up to the plate; and Peter & Sylvan continue to purchase shares.
I view the Chrome financing of $250,000, instead of a larger amount, as a good thing. Makes sense to finance in tranches at this point rather than a big lump 1) because the share price is so depressed - better terms might be possible after some volumetrics are determined for Block 11A and the market improves; 2) they have to pay interest on the financing amount, so less is better; 3) helps to encourage economizing on the part of management. If SEO hopes to preserve his investment, this will be repeated.
I think ERHC needs to go into a semi-hibernation (all the while doing what they can with Kenya & Chad) until this oil market depression subsides. That might mean asking Chad for an extension. Or shedding an asset or two. I don't know how realistic it is to expect a farm-in right now, when so many companies are shedding assets, not buying them. They certainly are not going to get top dollar.
It should be clear to management by now that convertible debt financing is the road to oblivion, especially with the oil market in the state that it is in now. Every dollar counts, and they have to batten down the hatches if they are going to weather the storm.
Management has all the more incentive to do so as they continue to ante up their stakes in the company. - LT
Any fool can criticize, condemn and complain and most fools do. – Benjamin Franklin
What is a cynic? A man who knows the price of everything and the value of nothing. – Oscar Wilde
Recent ERHE News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/06/2024 07:31:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:06:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 05:35:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM